Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for low cardiac output syndrome after cardiovascular surgery
ChiCTR2000032673Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levosimendan in low cardiac output syndrome (LCOS) (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: Low cardiac output syndrome. Planned start May 2020; status: not yet recruiting.
02
Drugs
levosimendan
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on ChiCTR2000032673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032673.